Skip to main content
Internal Medicine
ALL Specialities
ALL Specialities
/
Internal Medicine
CME
COVID-19 Updates
Diseases & Conditions
Asthma
Diabetes
Musculoskeletal Disorders
Obesity
Pain
Rare Diseases
Subspecialties
Addiction Medicine
Adolescent Medicine
Cardiology
Critical Care
Dermatology
Endocrinology
Gastroenterology
Geriatrics
Hematology
Hepatology
Hospice & Palliative Medicine
Immunology
Infectious Diseases
Men's Health
Mental Health
Nephrology
Neurology
Oncology
Pulmonology
Rheumatology
Sleep Medicine
Transgender Health
Women's Health
Multimedia
Audio
Podcasts
Video
Business of Medicine
News
Hepatitis Outlook: March 2016
Publish date:
April 5, 2016
References
rpizzi@frontlinemedcom.com
On Twitter
@richpizzi
Pages
« first
1
2
Recommended Reading
Drug combo held up in real-world HCV study
MDedge Internal Medicine
FDA approves new treatment for chronic HCV genotypes 1 and 4
MDedge Internal Medicine
Sovaldi topped Medicare part D spending in 2014
MDedge Internal Medicine
Hepatitis B vaccine protection lasts 30 years
MDedge Internal Medicine
FDA revises Olysio label after adverse reactions in East Asian patients
MDedge Internal Medicine
Lessons from the Indiana HIV/HCV outbreak
MDedge Internal Medicine
Birth-cohort HCV testing misses one-quarter of infections
MDedge Internal Medicine
HCV risk sixfold higher with HIV
MDedge Internal Medicine
Test all kidney transplant patients for hepatitis E
MDedge Internal Medicine
Privacy measure inadvertently suppresses substance abuse data
MDedge Internal Medicine
Infectious Diseases
Gastroenterology
Hepatology
All Specialties
